Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin ER in Postherpetic Neuralgia
NCT00335933Phase 3Completed
- Sponsor
- Assertio
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in postherpetic neuralgia (PHN), sponsored by Assertio. Started May 2006; status: completed.
02
Drugs
gabapentin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00335933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335933.